Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

New research uses AI to engineer enzymes with intricate active sites, expanding the possibilities for synthetic biocatalysts.

Sometimes, in order to go big, you first have to go small. That's what researchers at the Department of Energy's Pacific Northwest ...

Was it simply a fluke that he kept treating strikingly young patients? Or was his practice one tiny data point in a larger ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

Researchers have developed a novel experimental platform to measure the electric fields of light trapped between two mirrors with a sub-cycle precision. These electro-optic Fabry-Perot resonators will ...

PONTIAC — Within its first decade of operation, the Underground Railroad was estimated to have helped about 100,000 enslaved ...

The answer lies in how infected individuals invest into controlling pathogen proliferation and mitigating damage, two strategies respectively called resistance and disease tolerance. Pathogen ...

Clinical trials have been pivotal to the improvements in public health and clinical care, leading to many millions of additional years of healthy life globally. Some examples of disease areas in which ...

There are plenty of reasons to stay in Canberra this weekend, and we've found them all. Fere are 50+ events to keep you ...

One (though it doesn’t start until Sun/16) is “40 Years of Queer,” a six-week roundup of LGBTQ+ titles at the Roxie, co-curated by that venue’s Lex Sloan and longtime Bay Area-based filmmaker, ...